Circassia
Business Services · United Kingdom · 51-200 Employees
View Company Info for Free
Overview
Headquarters
Northbrook House Robert Robinson Avenue ...Phone Number
+44 1865405560Website
www.circassia.comRevenue
$34.2 MillionStock Symbol
CIRIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
1
1
1
1
1
About Circassia
Circassia is a dedicated diagnostics and management company focused on asthma. The company was established in 2006 and is based out of Oxford, UK.Explore more
Circassia Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Circassia your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Click to see if Circassia had a recent Job posting/layoffs
Website visits: Recent activity has been detected on your website
Circassia, which may be a good buyer, showed buying intent in Masked Content Topic
Check if Circassia has recently received funding, and reach out quickly before it becomes old news!
Congratulate Masked Content for being promoted to Masked Content at Circassia
Earning: See what the market has to say on Circassia recently announced quarterly report
Check out if Circassia is spiking on competitors!
Product Launch: Get notified when Circassia launches new products
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Funding: Get notified immidiatlly once Circassia has new funding data
Recommended Actions
Reach out to Masked Content who joined Circassia as Masked Content
Find more new buyers
Compare Similar Companies to Circassia
Compare insights from companies similar to Circassia, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
$75.3M
201-500
Public
$521.5M
1999
KN
Kyung Nam-WortmanExecutive Vice President & Chief Human Resources Officer
Company Profile Activity
Activity Insights
Circassia is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Circassia is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Circassia.
Circassia financials insights
Gather financial insights about Circassia, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2007
Series A
$7.5M
2008
Series B
$21.8M
2009
Series C
$25M
2011
Series D
$98M
2012
Other Financing Round
$154M
Series E
$19M
2015
Stock Offering
$342M
Circassia Tech Stack
A closer look at the technologies used by Circassia
See more technologies
Most Recent Scoops
Left Company
Management Move
Cortney Gallo, Manager, Territory Business, has left the organization and now serves as the Regional Sales Director, Florida (North) at Onco360.
Facilities Relocation / Expansion
Circassia is planning to move its offices in June 2021. The move will impact approximately 35 employees at their existing office located at 5151 Mccrimmon Parkway, Morrisville, NC.
Real Estate
Executive Move
Executive Moves, Board of Directors
New Hire
Executive Move
Jonathan Emms has been named Chief Operating Officer. In this role, Emms is responsible for operational management as well as the global commercial strategy of the company.
Executive Moves, New Hire
Executive Move
Executive Moves, Board of Directors
Circassia News & Media
Circassia Inc. Significantly Expands Reach of NIOX® FeNO Asthma Testing and Management Device With National Primary Care Distributor Agreements
MORRISVILLE, N.C.--(BUSINESS WIRE)-- #AsthmaAwarenessMonth--Circassia Inc. announced today that it has successfully engaged with major primary care national sales partners to expand the distribution of NIOX VERO®, its FeNO testing device in the United States. FeNO (fractional exhaled nitric oxide) is used to assess airway inflammation, one of the key characteristics of asthma. NIOX VERO® rapidly and accurately measures FeNO levels in a single breath, at the point-of-care. Circassia’s NIOX® produCircassia Group Plc (LON:CIR) Is About To Turn The Corner
With the business potentially at an important milestone, we thought we'd take a closer look at Circassia Group Plc's...The Executive Chairman of Circassia Group Plc (LON:CIR), Ian Johnson, Just Bought 38% More Shares
Whilst it may not be a huge deal, we thought it was good to see that the Circassia Group Plc ( LON:CIR ) Executive...Circassia Group Plc (LON:CIR) Shares Could Be 45% Below Their Intrinsic Value Estimate
Does the September share price for Circassia Group Plc ( LON:CIR ) reflect what it's really worth? Today, we will...
Read more news
Top Business Services Companies
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Circassia
Sign Up For FreeTo access detailed company insights
Circassia is a dedicated diagnostics and management company focused on asthma. The company was established in 2006 and is based out of Oxford, UK.... Read More
